- Hospira (NYSE:HSP -0.4%) Q1 results: Revenues: $1,174.9M (+11.8%); COGS: $651.4M (-4.4%); R&D Expense: $135.4M (+62.7%); SG&A: $223.6M (+20.2%); Operating Income: $133.4M (+33.9%); Net Income: $75.6M (+11.3%); EPS: $0.43 (+7.5%); Quick Assets: $643.7M (-19.8%); CF Ops: ($100.3M) (-648.1%).
- Revenue by region: America: $976.9M (+16.0%); EMEA: $118.5M (-10.7%); APAC: $79.5M (+4.2%).
- Revenue by business: Specialty Injectable Pharmaceuticals: $808.5M (+12.9%); Medication Management: $203.8M (-1.2%); Other Pharma: $162.6M (+26.7%).
- No guidance given.